(VIANEWS) – Cliffs Natural Resources (CLF), HollyFrontier Corporation (HFC), Ulta Beauty (ULTA) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Cliffs Natural Resources (CLF)

147.6% sales growth and 34.31% return on equity

Cleveland-Cliffs Inc. operates as an independent iron ore mining company in the United States, Canada, and internationally.

Cliffs Natural Resources’s sales growth this year is anticipated to be 280% and a negative 9.1% for next year.

Year-on-year quarterly revenue growth grew by 361.6%, now sitting on 13B for the twelve trailing months.

Volume

Today’s last reported volume for Cliffs Natural Resources is 14825600 which is 24.34% below its average volume of 19597100.

Cliffs Natural Resources’s sales growth for the next quarter is 147.6%. The company’s growth estimates for the current quarter and the next is 7300% and 5525%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.31%.

Volatility

Cliffs Natural Resources’s last day, last week, and last month’s current intraday variation average was 0.73%, 3.26%, and 2.45%, respectively.

Cliffs Natural Resources’s highest amplitude of average volatility was 5.81% (day), 4.79% (last week), and 4.81% (last month), respectively.

Cliffs Natural Resources’s Stock Yearly Top and Bottom Value

Cliffs Natural Resources’s stock is valued at $22.05 at 10:22 EST, way under its 52-week high of $26.51 and way higher than its 52-week low of $8.10.

Cliffs Natural Resources’s Moving Average

Cliffs Natural Resources’s value is higher than its 50-day moving average of $21.86 and higher than its 200-day moving average of $21.84.

2. HollyFrontier Corporation (HFC)

17.7% sales growth and 9.6% return on equity

HollyFrontier Corporation operates as an independent petroleum refiner in the United States.

HollyFrontier Corporation’s sales growth this year is anticipated to be 57.1% and 14.1% for next year.

Year-on-year quarterly revenue growth grew by 66.2%, now sitting on 15.67B for the twelve trailing months.

Volume

Today’s last reported volume for HollyFrontier Corporation is 687614 which is 58.78% below its average volume of 1668190.

HollyFrontier Corporation’s sales growth for the next quarter is 17.7%. The company’s growth estimates for the current quarter and the next is 181.1% and 186.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.6%.

Volatility

HollyFrontier Corporation’s last day, last week, and last month’s current intraday variation average was 0.37%, 0.95%, and 1.64%, respectively.

HollyFrontier Corporation’s highest amplitude of average volatility was 1.69% (day), 2.75% (last week), and 3.55% (last month), respectively.

HollyFrontier Corporation’s Stock Yearly Top and Bottom Value

HollyFrontier Corporation’s stock is valued at $32.78 at 10:22 EST, way below its 52-week high of $42.39 and way above its 52-week low of $24.60.

HollyFrontier Corporation’s Moving Average

HollyFrontier Corporation’s value is under its 50-day moving average of $33.20 and below its 200-day moving average of $33.08.

3. Ulta Beauty (ULTA)

15.7% sales growth and 39.86% return on equity

Ulta Beauty, Inc. operates as a beauty retailer in the United States.

Ulta Beauty’s sales growth this year is expected to be 35.2% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 60.2%, now sitting on 7.66B for the twelve trailing months.

Volume

Today’s last reported volume for Ulta Beauty is 883907 which is 11.29% above its average volume of 794214.

Ulta Beauty’s sales growth is a negative 0% for the ongoing quarter and 15.7% for the next. The company’s growth estimates for the present quarter and the next is 40.2% and 16.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.86%.

Volatility

Ulta Beauty’s last day, last week, and last month’s current intraday variation average was 0.98%, 1.55%, and 1.03%, respectively.

Ulta Beauty’s highest amplitude of average volatility was 3.94% (day), 4.07% (last week), and 2.66% (last month), respectively.

Ulta Beauty’s Stock Yearly Top and Bottom Value

Ulta Beauty’s stock is valued at $374.48 at 10:22 EST, way under its 52-week high of $417.85 and way higher than its 52-week low of $258.00.

Ulta Beauty’s Moving Average

Ulta Beauty’s worth is under its 50-day moving average of $387.53 and above its 200-day moving average of $352.83.

4. Haemonetics Corporation (HAE)

15.3% sales growth and 4.57% return on equity

Haemonetics Corporation, a healthcare company, provides hematology products and solutions.

Haemonetics Corporation’s sales growth this year is anticipated to be 14.6% and 3.5% for next year.

Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 933.83M for the twelve trailing months.

Volume

Today’s last reported volume for Haemonetics Corporation is 342955 which is 27.75% below its average volume of 474730.

Haemonetics Corporation’s sales growth is a negative 0% for the ongoing quarter and 15.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 9.9% and 52.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.57%.

Volatility

Haemonetics Corporation’s last day, last week, and last month’s current intraday variation average was 0.98%, 0.93%, and 2.56%, respectively.

Haemonetics Corporation’s highest amplitude of average volatility was 3.48% (day), 2.90% (last week), and 3.80% (last month), respectively.

Haemonetics Corporation’s Stock Yearly Top and Bottom Value

Haemonetics Corporation’s stock is valued at $53.04 at 10:22 EST, way under its 52-week high of $142.11 and above its 52-week low of $49.26.

Haemonetics Corporation’s Moving Average

Haemonetics Corporation’s value is under its 50-day moving average of $58.67 and way under its 200-day moving average of $67.13.

5. Automatic Data Processing (ADP)

10.8% sales growth and 45.5% return on equity

Automatic Data Processing, Inc. provides cloud-based human capital management solutions worldwide.

Automatic Data Processing’s sales growth this year is anticipated to be 6.8% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 10.7%, now sitting on 15.01B for the twelve trailing months.

Volume

Today’s last reported volume for Automatic Data Processing is 1929350 which is 33.24% above its average volume of 1448010.

Automatic Data Processing’s sales growth for the next quarter is 10.8%. The company’s growth estimates for the current quarter and the next is 5.7% and 7.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.5%.

Volatility

Automatic Data Processing’s last day, last week, and last month’s current intraday variation average was 1.39%, 1.28%, and 1.10%, respectively.

Automatic Data Processing’s highest amplitude of average volatility was 2.50% (day), 2.12% (last week), and 1.81% (last month), respectively.

Automatic Data Processing’s Stock Yearly Top and Bottom Value

Automatic Data Processing’s stock is valued at $228.75 at 10:22 EST, below its 52-week high of $241.18 and way above its 52-week low of $159.31.

Automatic Data Processing’s Moving Average

Automatic Data Processing’s value is higher than its 50-day moving average of $223.78 and way above its 200-day moving average of $204.79.

Previous days news about Automatic Data Processing(ADP)

  • According to Benzinga on Wednesday, 12 January, "This, as well as the speed and efficiency of the network, is what the company believes sets it apart from the competition and has led to it partnering with Automatic Data Processing Inc (NASDAQ:ADP)."

6. Manhattan Associates (MANH)

7.7% sales growth and 51.77% return on equity

Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations.

Manhattan Associates’s sales growth this year is anticipated to be 11.7% and 8.1% for next year.

Year-on-year quarterly revenue growth grew by 13%, now sitting on 639.23M for the twelve trailing months.

Volume

Today’s last reported volume for Manhattan Associates is 244448 which is 17.94% below its average volume of 297923.

Manhattan Associates’s sales growth for the next quarter is 7.7%. The company’s growth estimates for the current quarter and the next is a negative 13.3% and 4.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 51.77%.

Volatility

Manhattan Associates’s last day, last week, and last month’s current intraday variation average was 1.06%, 2.22%, and 1.76%, respectively.

Manhattan Associates’s highest amplitude of average volatility was 5.93% (day), 4.57% (last week), and 3.34% (last month), respectively.

Manhattan Associates’s Stock Yearly Top and Bottom Value

Manhattan Associates’s stock is valued at $139.42 at 10:22 EST, way under its 52-week high of $188.52 and way higher than its 52-week low of $109.71.

Manhattan Associates’s Moving Average

Manhattan Associates’s worth is way under its 50-day moving average of $160.99 and under its 200-day moving average of $149.80.

7. Evertec (EVTC)

5.8% sales growth and 41.27% return on equity

EVERTEC, Inc. engages in transaction processing business serving financial institutions, merchants, corporations, and government agencies in Latin America and the Caribbean.

Evertec’s sales growth this year is expected to be 13.7% and 5.8% for next year.

Year-on-year quarterly revenue growth grew by 6.9%, now sitting on 568.76M for the twelve trailing months.

Volume

Today’s last reported volume for Evertec is 126205 which is 58.19% below its average volume of 301858.

Evertec’s sales growth for the next quarter is 5.8%. The company’s growth estimates for the current quarter and the next is 5.1% and 6.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.27%.

Volatility

Evertec’s last day, last week, and last month’s current intraday variation average was 0.38%, 0.55%, and 1.73%, respectively.

Evertec’s highest amplitude of average volatility was 1.15% (day), 1.73% (last week), and 2.90% (last month), respectively.

Evertec’s Stock Yearly Top and Bottom Value

Evertec’s stock is valued at $49.98 at 10:22 EST, under its 52-week high of $51.06 and way above its 52-week low of $33.85.

Evertec’s Moving Average

Evertec’s value is above its 50-day moving average of $45.98 and way above its 200-day moving average of $44.16.

LEAVE A REPLY

Please enter your comment!
Please enter your name here